DD202025A5 - Verfahren zur herstellung von neuen n-substituierten polyglycidyl-urazolverbindungen - Google Patents

Verfahren zur herstellung von neuen n-substituierten polyglycidyl-urazolverbindungen Download PDF

Info

Publication number
DD202025A5
DD202025A5 DD82236947A DD23694782A DD202025A5 DD 202025 A5 DD202025 A5 DD 202025A5 DD 82236947 A DD82236947 A DD 82236947A DD 23694782 A DD23694782 A DD 23694782A DD 202025 A5 DD202025 A5 DD 202025A5
Authority
DD
German Democratic Republic
Prior art keywords
radical
reaction
radicals
compounds
glycidyl
Prior art date
Application number
DD82236947A
Other languages
German (de)
English (en)
Inventor
Herbert Fischer
Brigitte Hase
Hinrich Moeller
Hans-Christoph Wilk
Ulrich Zeidler
Original Assignee
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kgaa filed Critical Henkel Kgaa
Publication of DD202025A5 publication Critical patent/DD202025A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Resins (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
DD82236947A 1981-01-24 1982-01-25 Verfahren zur herstellung von neuen n-substituierten polyglycidyl-urazolverbindungen DD202025A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813102373 DE3102373A1 (de) 1981-01-24 1981-01-24 "neue n-substituierte polyglycidyl-urazolverbindungen, verfahren zu ihrer herstellung sowie pharmzeutische zubereitungen

Publications (1)

Publication Number Publication Date
DD202025A5 true DD202025A5 (de) 1983-08-24

Family

ID=6123305

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82236947A DD202025A5 (de) 1981-01-24 1982-01-25 Verfahren zur herstellung von neuen n-substituierten polyglycidyl-urazolverbindungen

Country Status (21)

Country Link
US (1) US4801601A (fr)
EP (1) EP0056962B1 (fr)
JP (1) JPS57142982A (fr)
KR (1) KR880001106B1 (fr)
AT (1) ATE15898T1 (fr)
AU (1) AU548803B2 (fr)
CA (1) CA1197847A (fr)
CS (1) CS252809B2 (fr)
DD (1) DD202025A5 (fr)
DE (2) DE3102373A1 (fr)
DK (1) DK27882A (fr)
ES (1) ES508992A0 (fr)
FI (1) FI71934C (fr)
HU (1) HU189557B (fr)
IE (1) IE51930B1 (fr)
IL (1) IL64844A (fr)
NO (1) NO820201L (fr)
NZ (1) NZ199485A (fr)
PL (1) PL135459B1 (fr)
SU (2) SU1118287A3 (fr)
ZA (1) ZA82451B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3330640A1 (de) * 1983-08-25 1985-03-14 Henkel KGaA, 4000 Düsseldorf Verfahren zur addition von saeuren an glycidylverbindungen
DE3336693A1 (de) * 1983-10-08 1985-04-25 Henkel KGaA, 4000 Düsseldorf Antitumormittel
US20090104254A1 (en) 2004-12-22 2009-04-23 Rutgers, The State University Of New Jersey Controlled Release Hydrogels
WO2012050591A1 (fr) 2010-10-15 2012-04-19 Rutgers, The State University Of New Jersey Formulation d'hydrogel pour une administration dermique et oculaire

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935354A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Triglycidyl-triazolidin-3,5-dione und verfahren zu ihrer herstellung
DE3175281D1 (en) * 1980-01-31 1986-10-16 Henkel Kgaa Medicaments with cytostatic activity and use of cyclic compounds, in which the heterocyclic n-ring atoms are substituted by several glycidyl groups, in pharmaceutical compositions
DE3027623A1 (de) * 1980-07-21 1982-02-18 Bayer Ag, 5090 Leverkusen Neue glycidyl-1,2,4-triazolidin-3,5-dione und ein verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CS50782A2 (en) 1986-12-18
ZA82451B (en) 1982-12-29
PL135459B1 (en) 1985-10-31
PL234828A1 (en) 1983-04-11
SU1118287A3 (ru) 1984-10-07
DE3102373A1 (de) 1982-08-26
IL64844A0 (en) 1982-03-31
EP0056962A2 (fr) 1982-08-04
ES8302695A1 (es) 1982-12-01
IE820133L (en) 1982-07-24
CS252809B2 (en) 1987-10-15
JPS57142982A (en) 1982-09-03
ATE15898T1 (de) 1985-10-15
EP0056962B1 (fr) 1985-10-02
HU189557B (en) 1986-07-28
FI71934B (fi) 1986-11-28
NO820201L (no) 1982-07-26
ES508992A0 (es) 1982-12-01
IE51930B1 (en) 1987-04-29
SU1074405A3 (ru) 1984-02-15
EP0056962A3 (en) 1982-08-25
NZ199485A (en) 1984-05-31
DE3266588D1 (en) 1985-11-07
AU548803B2 (en) 1986-01-02
FI820201L (fi) 1982-07-25
IL64844A (en) 1986-10-31
KR880001106B1 (ko) 1988-06-29
KR830009063A (ko) 1983-12-17
DK27882A (da) 1982-07-25
US4801601A (en) 1989-01-31
AU7974382A (en) 1982-08-05
FI71934C (fi) 1987-03-09
CA1197847A (fr) 1985-12-10

Similar Documents

Publication Publication Date Title
EP0071904A1 (fr) Composés hétérocycliques substitués par deux groupements glycidyle, procédé pour leur préparation et leur utilisation dans des médicaments à activité cytostatique
DD153370A5 (de) Verfahren zur herstellung neuer isocyanursaeureverbindungen
EP0046243B1 (fr) Médicaments à activité cytostatique, dérivés de l'acide isocyanurique et procédé pour leur préparation
DD202025A5 (de) Verfahren zur herstellung von neuen n-substituierten polyglycidyl-urazolverbindungen
DE3133077A1 (de) Neue cytostatisch wirksame epoxidgruppen tragende 1,3,2-oxazaphosphorin-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung in pharmazeutischen zubereitungen
DE2129960A1 (de) Benzolderivate
DE2907349C2 (de) Arzneimittel mit cytostatischer Wirksamkeit
DE2418142A1 (de) Tetracyclinderivate und verfahren zu ihrer herstellung
DE2812664A1 (de) Verwendung von dilignolen und dilignolaehnlichen verbindungen als wirkstoffe von lebertherapeutica
EP0033503A2 (fr) Médicaments à activité cytostatique et utilisation de composés cycliques, dont les N-hétérocycliques sont substitués par plusieurs groupes gycidyle, dans des formulations pharmaceutiques
EP0071903B1 (fr) Composés diglycidyl ptéridiniques, procédés pour leur préparation et leur utilisation dans des médicaments à activité cytostatique
EP0401652B1 (fr) Pipérazines 1-phényl-4-[3-(naphth-1-yloxy)-2-hydroxypropyliques] hydroxylées, procédé pour leur préparation et médicaments contenant ces composés
AT370729B (de) Verfahren zur herstellung von neuen diglycidyltriazinverbindungen
DE2901476C3 (de) N-(Tetrazol-5-yl)-prostaglandin-carboxamide
AT336617B (de) Verfahren zur herstellung von neuen heterocyclischen verbindungen
DE1793690C3 (de) 1 S-Hydroxy-9-oxoprosta-5-cis-10,13trans-triensäure und deren Salze sowie Verfahren zu ihrer Herstellung
EP0037062A2 (fr) 3-Aryl-2-cycloalcén-2-ones substitués, procédé pour leur préparation et leur application comme médicaments
EP0008108A2 (fr) Dérivés aminopropanolés de 2-(o-hydroxyphényl)-pyrroles, procédé de préparation et compositions pharmaceutiques les contenant
EP0137439A2 (fr) Agent antitumoral
CA1179266A (fr) Derives de l'acide isocyanurique, methode de preparation, composes therapeutiques cytostatiques et methode de traitement
DE2210121B2 (de) Pyrido eckige Klammer auf 2,3-b eckige Klammer zu indole, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2237549A1 (de) Mycophenolsaeure-verbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE2720915A1 (de) Neue 1-acyl-2-hydroxy-1,3-diaminopropane, verfahren zur herstellung derselben und arzneimittel
EP0011598A1 (fr) Procédé de préparation de dérivés de dimères de l'isoeugénol
DE2512674A1 (de) 8-alkylpyrido eckige klammer auf 3,4-d eckige klammer zu pyridazine und verfahren zu ihrer herstellung